Subsequent work revealed that in ErbB2-amplified human breast cancer cells, ErbB2 activates HSF1, which in turn binds to the LDHA gene promoter to induce LDHA expression and promote glycolysis and growth [78]. The gene discussed is LDHA; the disease is breast carcinoma.